1. Collision of metastatic malignant melanoma and acute myelogenous leukemia in the bone marrow

   • Nobuhiko Kobayashi
   • Hiroaki Shimizu
   • Hiroshi Handa

   Images in Hematology 17 October 2017 Pages: 257 - 259

   

2. Guest editorial: advances in immunotherapy for hematological malignancies

   • Norimitsu Kadowaki

   Progress in Hematology 09 February 2018 Pages: 260 - 261

3. NK cell therapy for hematologic malignancies

   • Rohtesh S. Mehta
   • Brion Randolph
   • Katayoun Rezvani

   Progress in Hematology 27 January 2018 Pages: 262 - 270

4. Cloning and expansion of antigen-specific T cells using iPS cell technology: development of “off-the-shelf” T cells for the use in allogeneic transfusion settings

   • Hiroshi Kawamoto
   • Kyoko Masuda
   • Takuya Maeda

   Progress in Hematology 31 January 2018 Pages: 271 - 277

   

5. Immunopathogenesis and immunotherapy of multiple myeloma

   • Hideto Tamura

   Progress in Hematology 24 January 2018 Pages: 278 - 285

   

6. Therapeutic doses of doxorubicin induce premature senescence of human mesenchymal stem cells derived from menstrual blood, bone marrow and adipose tissue

   • Irina Kozhukharova
   • Victoria Zemelko
   • Nikolay Nikolsky

   Original Article 11 October 2017 Pages: 286 - 296

   

7. Genetic variation of Krüppel-like factor 1 (KLF1) and fetal hemoglobin (HbF) levels in β⁰-thalassemia/HbE disease

   • Pinyaphat Khamphikham
   • Orapan Sripichai
   • Duncan R. Smith

   Original Article 24 October 2017 Pages: 297 - 310

   

8. Notch1 expression is regulated at the post-transcriptional level by the 3′ untranslated region in hematopoietic stem cell development

   • Shinichi Mizuno
   • Tadafumi Iino
   • Koichi Akashi

   Original Article 02 November 2017 Pages: 311 - 319

   

9. Immature platelet fraction (IPF) as a predictive value for thrombopoietic recovery after allogeneic stem cell transplantation

   • Mikiko Sakuragi
   • Satoru Hayashi
   • Yoshiaki Tomiyama

   Original Article 12 October 2017 Pages: 320 - 326

   

10. Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: long-term follow-up of the Japanese subgroup of the randomized ENESTnd trial

    • Hirohisa Nakamae
    • Tetsuya Fukuda
    • Hirohiko Shibayama

    Original Article 26 October 2017 Pages: 327 - 336

    

11. MAGI-1 expression is decreased in several types of human T-cell leukemia cell lines, including adult T-cell leukemia

    • Takashi Kozakai
    • Masahiko Takahashi
    • Masahiro Fujii

    Original Article 17 October 2017 Pages: 337 - 344

    

12. Enforced expression of MIR142, a target of chromosome translocation in human B-cell tumors, results in B-cell depletion

    • Kodai Kuriyama
    • Yutaka Enomoto
    • Takashi Sonoki

    Original Article 25 October 2017 Pages: 345 - 354

    

13. High-dose chemotherapy and autologous peripheral blood stem cell transplantation with BCVAC regimen followed by maintenance chemotherapy for children with very high risk acute lymphoblastic leukemia

    • Che Ry Hong
    • Hyoung Jin Kang
    • Hyo Seop Ahn

    Original Article 20 October 2017 Pages: 355 - 362

    

14. Analysis of five cases of human herpesvirus-6 myelitis among 121 cord blood transplantations

    • Toshimitsu Ueki
    • Kenichi Hoshi
    • Hikaru Kobayashi

    Original Article 11 October 2017 Pages: 363 - 372

    

15. Dasatinib-associated reversible demyelinating peripheral polyneuropathy in a case of chronic myeloid leukemia

    • Takashi Ishida
    • Naoyuki Akagawa
    • Koji Miyazaki

    Case Report 13 October 2017 Pages: 373 - 377

    

16. Long-term clinical remission maintained after cessation of zidovudine and interferon-α therapy in chronic adult T-cell leukemia/lymphoma

    • Lucy B. Cook
    • Aileen G. Rowan
    • Graham P. Taylor

    Case Report 31 October 2017 Pages: 378 - 382

    

17. Cell adhesion-induced phosphorylation and inactivation of EZH2 confer drug resistance to acute myeloid leukemia cells

    • Jiro Kikuchi
    • Yoshiaki Kuroda
    • Yusuke Furukawa

    Letter to the Editor 28 November 2017 Pages: 383 - 385